The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Long term hormone therapy for perimenopausal and postmenopausal women
Abstract
BACKGROUND: Hormone therapy (HT) is widely used for controlling menopausal symptoms and has also been used for the management and prevention of cardiovascular disease, osteoporosis and dementia in older women. This is an updated version of a Cochrane review first published in 2005. OBJECTIVES: To assess the effects of long term HT on mortality, cardiovascular outcomes, cancer, gallbladder disease, fractures, cognition and quality of life in perimenopausal and postmenopausal women, both during HT use and after cessation of HT use. SEARCH METHODS: We searched the following databases to February 2012: Cochrane Menstrual Disorders and Subfertility Group Trials Register, Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, PsycINFO. SELECTION CRITERIA: We included randomised double-blind studies of HT versus placebo, taken for at least one year by perimenopausal or postmenopausal women. HT included oestrogens, with or without progestogens, via oral, transdermal, subcutaneous or intranasal routes. DATA COLLECTION AND ANALYSIS: Two authors independently assessed study quality and extracted data. We calculated risk ratios (RRS) for dichotomous data and mean differences (MDs) for continuous data, with 95% confidence intervals (CIs). Where findings were statistically significant, we calculated the absolute risk (AR) in the intervention group (the overall risk of an event in women taking HT). MAIN RESULTS: Twenty-three studies involving 42,830 women were included. Seventy per cent of the data were derived from two studies (WHI 1998 and HERS 1998). Most participants were postmenopausal American women with at least some degree of co-morbidity, and the mean participant age in most studies was over 60 years. None of the studies focused on perimenopausal women. In relatively healthy postmenopausal women (that is generally fit, without overt disease) combined continuous HT significantly increased the risk of a coronary event (after one year's use: AR 4 per 1000, 95% CI 3 to 7), venous thrombo-embolism (after one year's use: AR 7 per 1000, 95% CI 4 to 11), stroke (after three years' use: AR 18 per 1000, 95% CI 14 to 23), breast cancer (after 5.6 years' use: AR 23 per 1000, 95% CI 19 to 29), gallbladder disease (after 5.6 years' use: AR 27 per 1000, 95% CI 21 to 34) and death from lung cancer (after 5.6 years' use plus 2.4 years' additional follow-up: AR 9 per 1000, 95% CI 6 to 13). Oestrogen-only HT significantly increased the risk of venous thrombo-embolism (after one to two years' use: AR 5 per 1000, 95% CI 2 to 10; after 7 years' use: AR 21 per 1000, 95% CI 16 to 28), stroke (after 7 years' use: AR 32 per 1000, 95% CI 25 to 40) and gallbladder disease (after seven years' use: AR 45 per 1000, 95% CI 36 to 57) but did not significantly increase the risk of breast cancer. Among women aged over 65 years who were relatively healthy and taking continuous combined HT, there was a statistically significant increase in the incidence of dementia (after 4 years' use: AR 18 per 1000, 95% CI 11 to 30). Among women with cardiovascular disease, long term use of combined continuous HT significantly increased the risk of venous thrombo-embolism (at one year: AR 9 per 1000, 95% CI 3 to 29). Women taking HT had a significantly decreased incidence of fractures with long term use (after 5.6 years of combined HT: AR 86 per 1000, 95% CI 79 to 84; after 7.1 years' use of oestrogen-only HT: AR 102 per 1000, 95% CI 91 to 112). Risk of fracture was the only outcome for which there was strong evidence of clinical benefit from HT. There was no strong evidence that HT has a clinically meaningful impact on the incidence of colorectal cancer.One trial analysed subgroups of 2839 relatively healthy 50 to 59 year old women taking combined continuous HT and 1637 taking oestrogen-only HT versus similar-sized placebo groups. The only significantly increased risk reported was for venous thrombo-embolism in women taking combined continuous HT: their absolute risk remained low, at less than 1/500. However, other differences in risk cannot be excluded as this study was not designed to have the power to detect differences between groups of women within 10 years of the menopause. AUTHORS' CONCLUSIONS: HT is not indicated for primary or secondary prevention of cardiovascular disease or dementia, nor for preventing deterioration of cognitive function in postmenopausal women. Although HT is considered effective for the prevention of postmenopausal osteoporosis, it is generally recommended as an option only for women at significant risk, for whom non-oestrogen therapies are unsuitable. There are insufficient data to assess the risk of long term HT use in perimenopausal women or postmenopausal women younger than 50 years of age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Breast cancer and hormone-replacement therapy in the Million Women Study
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,993
Design of the Women’s Health Initiative Clinical Trial and Observational Study
(1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00078-0 · Cited by 2,585
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320
Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
Estrogen plus Progestin and the Risk of Coronary Heart Disease
Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., Trevisan, M., Black, H. R., Heckbert, S. R., Detrano, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030808 · Cited by 2,065
Grady, D., Herrington, D., Bittner, V., Blumenthal, R., Davidson, M., Hlatky, M., Hsia, J., Hulley, S., Herd, A., Khan, S., et al. (2002) · JAMA · doi:10.1001/jama.288.1.49 · Cited by 1,930
Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M., Lane, D., Rodabough, R. J., Gilligan, M. A., Cyr, M. G., Thomson, C. A., et al. (2003) · JAMA · doi:10.1001/jama.289.24.3243 · Cited by 1,872
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause
Rossouw, J. E., Prentice, R. L., Manson, J. E., Wu, L., Barad, D., Barnabei, V. M., Ko, M., LaCroix, A. Z., Margolis, K. L., & Stefanick, M. L. (2007) · JAMA · doi:10.1001/jama.297.13.1465 · Cited by 1,741
Kurman, R. J., Kaminski, P. F., & Norris, H. J. (1985) · Cancer · doi:10.1002/1097-0142(19850715)56:2<403::aid-cncr2820560233>3.0.co;2-x · Cited by 1,252
Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis
Herrington, D. M., Reboussin, D. M., Brosnihan, K. B., Sharp, P. C., Shumaker, S. A., Snyder, T. E., Furberg, C. D., Kowalchuk, G. J., Stuckey, T. D., Rogers, W. J., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008243430801 · Cited by 1,242
Cauley, J. A. (2003) · JAMA · doi:10.1001/jama.290.13.1729 · Cited by 1,221
Wassertheil-Smoller, S., Hendrix, S., Limacher, M., Heiss, G., Kooperberg, C., Baird, A., Kotchen, T., Curb, J. D., Black, H., Rossouw, J. E., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2673 · Cited by 1,159
Mulnard, R. A., Cotman, C. W., Kawas, C., van Dyck, C. H., Sano, M., Doody, R., Koss, E., Pfeiffer, E., Jin, S., Gamst, A., et al. (2000) · JAMA · doi:10.1001/jama.283.8.1007 · Cited by 991
Hormone replacement therapy and endometrial cancer risk: A meta-analysis
GRADY, D., GEBRETSADIK, T., KERLIKOWSKE, K., ERNSTER, V, & PETITTI, D. (1995) · Obstetrics & Gynecology · doi:10.1016/0029-7844(94)00383-o · Cited by 962
LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN
Lindsay, R., Aitken, J. M., Anderson, L. B., Hart, D. M., Macdonald, E. B., & Clarke, A. C. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92217-0 · Cited by 952
Rapp, S. R., Espeland, M. A., Shumaker, S. A., Henderson, V. W., Brunner, R. L., Manson, J. E., Gass, M. L. S., Stefanick, M. L., Lane, D. S., Hays, J., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2663 · Cited by 930
A Clinical Trial of Estrogen-Replacement Therapy after Ischemic Stroke
Viscoli, C. M., Brass, L. M., Kernan, W. N., Sarrel, P. M., Suissa, S., & Horwitz, R. I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010534 · Cited by 921
Canonico, M., Oger, E., Plu-Bureau, G., Conard, J., Meyer, G., Lévesque, H., Trillot, N., Barrellier, M.-T., Wahl, D., Emmerich, J., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.642280 · Cited by 864
Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen
Lufkin, E. G., Wahner, H. W., O'Fallon, W. M., Hodgson, S. F., Kotowicz, M. A., Lane, A. W., Judd, H. L., Caplan, R. H., & Riggs, B. L. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-1-1 · Cited by 810
Espeland, M. A. (2004) · JAMA · doi:10.1001/jama.291.24.2959 · Cited by 795
The women's health initiative recruitment methods and results
Hays, J., Hunt, J. R., Hubbell, F. A., Anderson, G. L., Limacher, M., Allen, C., & Rossouw, J. E. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00042-5 · Cited by 742
Grady, D., Wenger, N. K., Herrington, D., Khan, S., Furberg, C., Hunninghake, D., Vittinghoff, E., Hulley, S., & for the Heart and Estrogen/progestin Replacement Study Research Group (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-9-200005020-00002 · Cited by 715
Estrogen in the Prevention of Atherosclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Hodis, H. N., Mack, W. J., Lobo, R. A., Shoupe, D., Sevanian, A., Mahrer, P. R., Selzer, R. H., Liu, C.-R., Liu, C.-H., Azen, S. P., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-11-200112040-00005 · Cited by 687
Effects of estrogen plus progestin on health-related quality of life
Hays, J., Ockene, J. K., Brunner, R. L., Kotchen, J. M., Manson, J. E., Patterson, R. E., Aragaki, A. K., Shumaker, S. A., Brzyski, R. G., LaCroix, A. Z., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030311 · Cited by 686
Estrogen plus Progestin and Colorectal Cancer in Postmenopausal Women
Chlebowski, R. T., Wactawski-Wende, J., Ritenbaugh, C., Hubbell, F. A., Ascensao, J., Rodabough, R. J., Rosenberg, C. A., Taylor, V. M., Harris, R., Chen, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032071 · Cited by 669
Cushman, M., Legault, C., Barrett-Connor, E., Stefanick, M. L., Kessler, C., Judd, H. L., Sakkinen, P. A., & Tracy, R. P. (1999) · Circulation · doi:10.1161/01.cir.100.7.717 · Cited by 660
Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups
Avis, N. E., Stellato, R., Crawford, S., Bromberger, J., Ganz, P., Cain, V., & Kagawa-Singer, M. (2001) · Social Science & Medicine · doi:10.1016/s0277-9536(00)00147-7 · Cited by 643
Kanaya, A. M., Herrington, D., Vittinghoff, E., Lin, F., Grady, D., Bittner, V., Cauley, J. A., & Barrett-Connor, E. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00005 · Cited by 633
Estrogen plus progestin and risk of venous thrombosis
Cushman, M. (2004) · JAMA · doi:10.1001/jama.292.13.1573 · Cited by 632
Conjugated Equine Estrogens and Coronary Heart Disease: The Women's Health Initiative
Hsia, J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.3.357 · Cited by 610
IX: Summary of Meta-Analyses of Therapies for Postmenopausal Osteoporosis
Cranney, A., Guyatt, G., Griffith, L., Wells, G., Tugwell, P., Rosen, C., The Osteoporosis Methodology Group, & The Osteoporosis Research Advisory Group (2002) · Endocrine Reviews · doi:10.1210/er.2001-9002 · Cited by 604
Hulley, S., Furberg, C., Barrett-Connor, E., Cauley, J., Grady, D., Haskell, W., Knopp, R., Lowery, M., Satterfield, S., Schrott, H., et al. (2002) · JAMA · doi:10.1001/jama.288.1.58 · Cited by 595
HORMONE REPLACEMENT THERAPY, HEART DISEASE, AND OTHER CONSIDERATIONS
Barrett-Connor, E., & Grady, D. (1998) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.19.1.55 · Cited by 590
Waters, D. D., Alderman, E. L., Hsia, J., Howard, B. V., Cobb, F. R., Rogers, W. J., Ouyang, P., Thompson, P., Tardif, J. C., Higginson, L., et al. (2002) · JAMA · doi:10.1001/jama.288.19.2432 · Cited by 577
Stefanick, M. L., Anderson, G. L., Margolis, K. L., Hendrix, S. L., Rodabough, R. J., Paskett, E. D., Lane, D. S., Hubbell, F. A., Assaf, A. R., Sarto, G. E., et al. (2006) · JAMA · doi:10.1001/jama.295.14.1647 · Cited by 571
Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women
Chlebowski, R. T., Anderson, G. L., Gass, M., Lane, D. S., Aragaki, A. K., Kuller, L. H., Manson, J. E., Stefanick, M. L., Ockene, J., Sarto, G. E., et al. (2010) · JAMA · doi:10.1001/jama.2010.1500 · Cited by 567
Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
MacLennan, A. H., Broadbent, J. L., Lester, S., & Moore, V. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002978.pub2 · Cited by 543
LaCroix, A. Z. (2011) · JAMA · doi:10.1001/jama.2011.382 · Cited by 538
Holmberg, L., & Anderson, H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15493-7 · Cited by 533
Evidence from randomised trials on the long-term effects of hormone replacement therapy
Beral, V., Banks, E., & Reeves, G. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11032-4 · Cited by 487
Greendale, G. A., Lee, N. P., & Arriola, E. R. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05352-5 · Cited by 467
NACHTIGALL, L. E., NACHTIGALL, R. H., NACHTIGALL, R. D., & BECKMAN, M. E. (1979) · Obstetrics & Gynecology · doi:10.1097/00006250-197907000-00017 · Cited by 446
Postmenopausal Hormone Therapy and Change in Mammographic Density
Greendale, G. A., Reboussin, B. A., Slone, S., Wasilauskas, C., Pike, M. C., & Ursin, G. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.1.30 · Cited by 419
Simon, J. A., Hsia, J., Cauley, J. A., Richards, C., Harris, F., Fong, J., Barrett-Connor, E., & Hulley, S. B. (2001) · Circulation · doi:10.1161/01.cir.103.5.638 · Cited by 403
Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin
Heiss, G. (2008) · JAMA · doi:10.1001/jama.299.9.1036 · Cited by 396
Jensen, J., Christiansen, C., & Rødbro, P. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510173131602 · Cited by 382
Effects of Conjugated Equine Estrogen on Stroke in the Women’s Health Initiative
Hendrix, S. L., Wassertheil-Smoller, S., Johnson, K. C., Howard, B. V., Kooperberg, C., Rossouw, J. E., Trevisan, M., Aragaki, A., Baird, A. E., Bray, P. F., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.594077 · Cited by 359
Local oestrogen for vaginal atrophy in postmenopausal women
Suckling, J. A., Kennedy, R., Lethaby, A., & Roberts, H. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001500.pub2 · Cited by 359
Self-citationIncreased Risk of Recurrence After Hormone Replacement Therapy in Breast Cancer Survivors
Holmberg, L., Iversen, O.-E., Rudenstam, C. M., Hammar, M., Kumpulainen, E., Jaskiewicz, J., Jassem, J., Dobaczewska, D., Fjosne, H. E., Peralta, O., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn058 · Cited by 344
(2002) · The Lancet · doi:10.1016/s0140-6736(02)12001-0 · Cited by 333
Chlebowski, R. T., Schwartz, A. G., Wakelee, H., Anderson, G. L., Stefanick, M. L., Manson, J. E., Rodabough, R. J., Chien, J. W., Wactawski-Wende, J., Gass, M., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61526-9 · Cited by 322
The Women’s Health Initiative Memory Study (WHIMS)
Shumaker, S. A., Reboussin, B. A., Espeland, M. A., Rapp, S. R., McBee, W. L., Dailey, M., Bowen, D., Terrell, T., & Jones, B. N. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(98)00038-5 · Cited by 321
Barnabei, V. M., Cochrane, B. B., Aragaki, A. K., Nygaard, I., Williams, R. S., McGovern, P. G., Young, R. L., Wells, E. C., OʼSullivan, M. J., Chen, B., et al. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000158120.47542.18 · Cited by 320
Effects of Combination Estrogen Plus Progestin Hormone Treatment on Cognition and Affect
Resnick, S. M., Maki, P. M., Rapp, S. R., Espeland, M. A., Brunner, R., Coker, L. H., Granek, I. A., Hogan, P., Ockene, J. K., & Shumaker, S. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2097 · Cited by 310
Effect of Estrogen Therapy on Gallbladder Disease
Cirillo, D. J. (2005) · JAMA · doi:10.1001/jama.293.3.330 · Cited by 304
Hlatky, M. A., Boothroyd, D., Vittinghoff, E., Sharp, P., Whooley, M. A., & for the HERS Research Group (2002) · JAMA · doi:10.1001/jama.287.5.591 · Cited by 303
Mortality associated with hormone replacement therapy in younger and older women: A meta-analysis
Salpeter, S. R., Walsh, J. M. E., Greyber, E., Ormiston, T. M., & Salpeter, E. E. (2004) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2004.30281.x · Cited by 292
Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy
Beral, V., Reeves, G., Bull, D., Green, J., & Collaborators, F. T. M. W. S. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq527 · Cited by 292
Clarke, S. (2002) · BJOG: An International Journal of Obstetrics and Gynaecology · doi:10.1016/s1470-0328(02)01544-6 · Cited by 267
Heart and Estrogen/progestin Replacement Study (HERS)
Grady, D., Applegate, W., Bush, T., Furberg, C., Riggs, B., & Hulley, S. B. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(98)00010-5 · Cited by 260
Oestrogen Replacement Therapy for Prevention of Osteoporosis after Oophorectomy
Aitken, J. M., Hart, D. M., & Lindsay, R. (1973) · BMJ · doi:10.1136/bmj.3.5879.515 · Cited by 259
Vickers, M. R., MacLennan, A. H., Lawton, B., Ford, D., Martin, J., Meredith, S. K., DeStavola, B. L., Rose, S., Dowell, A., Wilkes, H. C., et al. (2007) · BMJ · doi:10.1136/bmj.39266.425069.ad · Cited by 254
Hemminki, E., & McPherson, K. (1997) · BMJ · doi:10.1136/bmj.315.7101.149 · Cited by 253
Angerer, P., Störk, S., Kothny, W., Schmitt, P., & von Schacky, C. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.2.262 · Cited by 240
Jackson, R. D., Wactawski-Wende, J., LaCroix, A. Z., Pettinger, M., Yood, R. A., Watts, N. B., Robbins, J. A., Lewis, C. E., Beresford, S. A., Ko, M. G., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060312 · Cited by 239
Anderson, G. L., Chlebowski, R. T., Rossouw, J. E., Rodabough, R. J., McTiernan, A., Margolis, K. L., Aggerwal, A., Curb, J. D., Hendrix, S. L., Hubbell, F. A., et al. (2006) · Maturitas · doi:10.1016/j.maturitas.2006.05.004 · Cited by 239
Barakat, R. R., Bundy, B. N., Spirtos, N. M., Bell, J., & Mannel, R. S. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8464 · Cited by 238
Association between hormone replacement therapy and subsequent stroke: a meta-analysis
Bath, P. M. W., & Gray, L. J. (2005) · BMJ · doi:10.1136/bmj.38331.655347.8f · Cited by 236
Herrington, D. M., Vittinghoff, E., Lin, F., Fong, J., Harris, F., Hunninghake, D., Bittner, V., Schrott, H. G., Blumenthal, R. S., & Levy, R. (2002) · Circulation · doi:10.1161/01.cir.0000019406.74017.b2 · Cited by 235
Komulainen, M. H., Kröger, H., Tuppurainen, M. T., Heikkinen, A.-M., Alhava, E., Honkanen, R., & Saarikoski, S. (1998) · Maturitas · doi:10.1016/s0378-5122(98)00085-1 · Cited by 235
Benefits and Risks of Postmenopausal Hormone Therapy When It Is Initiated Soon After Menopause
Prentice, R. L., Manson, J. E., Langer, R. D., Anderson, G. L., Pettinger, M., Jackson, R. D., Johnson, K. C., Kuller, L. H., Lane, D. S., Wactawski-Wende, J., et al. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp115 · Cited by 234
Stefanick, M. L., Cochrane, B. B., Hsia, J., Barad, D. H., Liu, J. H., & Johnson, S. R. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00045-0 · Cited by 232
Genant, H. K. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440430091011 · Cited by 228
Grady, D., Yaffe, K., Kristof, M., Lin, F., Richards, C., & Barrett-Connor, E. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01270-6 · Cited by 222
Hot flashes: phenomenology, quality of life, and search for treatment options
Kronenberg, F. (1994) · Experimental Gerontology · doi:10.1016/0531-5565(94)90012-4 · Cited by 217
Venous Thrombosis and Conjugated Equine Estrogen in Women Without a Uterus
Curb, J. D., Prentice, R. L., Bray, P. F., Langer, R. D., Van Horn, L., Barnabei, V. M., Bloch, M. J., Cyr, M. G., Gass, M., Lepine, L., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.7.772 · Cited by 217
Hormone replacement therapy for cognitive function in postmenopausal women
Lethaby, A., Hogervorst, E., Richards, M., Yesufu, A., & Yaffe, K. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003122.pub2 · Cited by 214
Self-citationWelton, A. J., Vickers, M. R., Kim, J., Ford, D., Lawton, B. A., MacLennan, A. H., Meredith, S. K., Martin, J., Meade, T. W., & for the WISDOM team (2008) · BMJ · doi:10.1136/bmj.a1190 · Cited by 205
Hormone therapy in postmenopausal women and risk of endometrial hyperplasia
Furness, S., Roberts, H., Marjoribanks, J., Lethaby, A., Hickey, M., & Farquhar, C. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000402.pub3 · Cited by 194
Self-citationSaitta, A., Altavilla, D., Cucinotta, D., Morabito, N., Frisina, N., Corrado, F., D’Anna, R., Lasco, A., Squadrito, G., Gaudio, A., et al. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0901.095565 · Cited by 188
Qvigstad, E., Arnesen, H., Larsen, S., Wickstrøm, E., Sandset, P., & Høibraaten, E. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614156 · Cited by 184
Hormone replacement therapy to maintain cognitive function in women with dementia
Hogervorst, E., Yaffe, K. S., Richards, M., & Huppert, F. A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003799.pub2 · Cited by 163
Estrogen replacement therapy for ovarian carcinoma survivors: A randomized controlled trial
Guidozzi, F., & Daponte, A. I. (1999) · Cancer · Cited by 160
de Valk-de Roo, G. W., Stehouwer, C. D. A., Meijer, P., Mijatovic, V., Kluft, C., Kenemans, P., Cohen, F., Watts, S., & Netelenbos, C. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.12.2993 · Cited by 158
Kongnyuy, E. J., Norman, R. J., Flight, I. H. K., & REES, M. C. P. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001018 · Cited by 157
The WHI Estrogen-Alone Trial—Do Things Look Any Better?
Hulley, S. B. (2004) · JAMA · doi:10.1001/jama.291.14.1769 · Cited by 156
Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women
Ismail, S. I. M. F., Bain, C., & Hagen, S. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007063.pub2 · Cited by 146
Oestrogen therapy for urinary incontinence in post-menopausal women
Cody, J. D., Richardson, K., Moehrer, B., Hextall, A., & Glazener, C. M. A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001405.pub2 · Cited by 141
Update in Hormone Therapy Use in Menopause
Taylor, H. S., & Manson, J. E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0536 · Cited by 137
Hot flushes during the menopause transition: a longitudinal study in Australian-born women
Guthrie, J. R., Dennerstein, L., Taffe, J. R., Lehert, P., & Burger, H. (2005) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000155200.80687.be · Cited by 135
Women's Health Initiative: Why now? What is it? What's new?
Matthews, K. A., Shumaker, S. A., Bowen, D. J., Langer, R. D., Hunt, J. R., Kaplan, R. M., Klesges, R. C., & Ritenbaugh, C. (1997) · American Psychologist · doi:10.1037/0003-066x.52.2.101 · Cited by 134
The postmenopausal estrogen/progestin interventions study: primary outcomes in adherent women
Barrett-Connor, E. L., Slone, S. A., Greendale, G. A., Kritz‐Silverstein, D. C., Espeland, M. A., Johnson, S. R., Waclawiw, M. A., & Fineberg, S. E. (1997) · Maturitas · doi:10.1016/s0378-5122(97)00041-8 · Cited by 130
Chlebowski, R. T., Anderson, G. L., Manson, J. E., Schwartz, A. G., Wakelee, H. A., Gass, M. L. S., Rodabough, R. J., Johnson, K., Wactawski‐Wende, J., Kotchen, J. M., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq285 · Cited by 125
Toh, S., Hernández–Díaz, S., Logan, R. W., Rossouw, J. E., & Hernán, M. Á. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-4-201002160-00005 · Cited by 123
Brunner, R. L. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.17.1976 · Cited by 122
Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis
Greiser, C. M., Greiser, E. M., & Dören, M. (2007) · Human Reproduction Update · doi:10.1093/humupd/dmm012 · Cited by 122
Banks, E., REEVES, G. K., Beral, V., Balkwill, A., Liu, B. C., Roddam, A., & Collaborators, F. T. M. W. S. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000181 · Cited by 122
Effects of Ultra–Low-Dose Transdermal Estradiol on Cognition and Health-Related Quality of Life
Yaffe, K. S., Vittinghoff, E., Ensrud, K. E., Johnson, K., Diem, S. J., Hanes, V., & Grady, D. G. (2006) · Archives of Neurology · doi:10.1001/archneur.63.7.945 · Cited by 118
Resnick, S. M., Cokerb, L. H., Maki, P. M., Rapp, S. R., Espeland, M. A., & Shumakerb, S. A. (2004) · Clinical Trials · doi:10.1191/1740774504cn040oa · Cited by 113
Qvigstad, E., Andersen, T. O., Mowinckel, M.-C., Sandset, P. M., & Høibraaten, E. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615717 · Cited by 109
Resnick, S. M., Espeland, M. A., An, Y., Maki, P. M., Coker, L. H., Jackson, R. D., Stefanick, M. L., Wallace, R. B., Rapp, S. R., & for the Women’s Health Initiative Study of Cognitive Aging Investigators (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1340 · Cited by 108
Ritenbaugh, C., Stanford, J. L., Wu, L., Shikany, J. M., Schoen, R. E., Stefanick, M. L., Taylor, V., Garland, C. F., Frank, G. C., Lane, D. S., et al. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0385 · Cited by 108
Estrogen Plus Progestin and Breast Cancer Detection by Means of Mammography and Breast Biopsy
Chlebowski, R. T. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.123 · Cited by 107
Hormone replacement therapy (HRT)— risks and benefits
Barrett-Connor, E. L., & Stuenkel, C. A. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.3.423 · Cited by 106
Wharton, W., Baker, L. D., Gleason, C. E., Dowling, N. M., Barnet, J. H., Johnson, S. C., Carlsson, C. M., Craft, S., & Asthana, S. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110341 · Cited by 104
Vittinghoff, E., Shlipak, M. G., Varosy, P. D., Furberg, C. D., Ireland, C. C., Khan, S. S., Blumenthal, R. S., Barrett-Connor, E. L., & Hulley, S. B. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-2-200301210-00007 · Cited by 103
Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women
Sánchez, R. G., Sánchez-Gómez, L. M., Carmona, L., Figuls, M. R. I., & Bonfill, X. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002229.pub2 · Cited by 101
Viscoli, C. M., Brass, L. M., Kernan, W. N., Sarrel, P. M., Suissa, S., & Horwitz, R. I. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.08.017 · Cited by 101
Simon, J. A., Hunninghake, D. B., Agarwal, S. K., Lin, F., Cauley, J. A., Ireland, C. C., & Pickar, J. H. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-7-200110020-00008 · Cited by 98
Walitt, B. T., Pettinger, M. B., Weinstein, A., Katz, J. D., Torner, J. C., Wasko, M. C., Howard, B. V., & Women's Health Initiative Investigators (2008) · Arthritis Care & Research · doi:10.1002/art.23325 · Cited by 98
Høibraaten, E., Mowinckel, M., de Ronde, H., Bertina, R. M., & Sandset, P. M. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03111.x · Cited by 96
Hormones and Heart Disease in Women: The Timing Hypothesis
Barrett-Connor, E. L. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm214 · Cited by 96
Shapiro, S. (2003) · Climacteric · doi:10.1080/713605431 · Cited by 84
Byington, R. P., Furberg, C. D., Herrington, D. M., Herd, J. A., Hunninghake, D. B., Lowery, M. H., Riley, W. A., Craven, T. E., Chaput, L. A., Ireland, C. C., et al. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000033514.79653.04 · Cited by 83
Tierney, M. C., OH, P. I., Moineddin, R., Greenblatt, E. M., Snow, W. G., Fisher, R. H., Iazzetta, J., George‐Hyslop, P. S., & MacLusky, N. J. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.02.009 · Cited by 77
The Estrogen Replacement and Atherosclerosis (ERA) Study
Herrington, D. M., Reboussin, D. M., Klein, K. P., Sharp, P. C., Shumaker, S. A., Snyder, T. E., & Geisinger, K. R. (2000) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00054-4 · Cited by 74
Menopause hormonal therapy in women with systemic lupus erythematosus
Sánchez‐Guerrero, J., González‐Pérez, M., Durand-Carbajal, M., Lara-Reyes, P., Jiménez-Santana, L., Romero‐Díaz, J., & Cravioto, M. D. C. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22855 · Cited by 71
The effect of hormone replacement on physical performance in community-dwelling elderly women
Greenspan, S. L., Resnick, N. M., & Parker, R. A. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.03.004 · Cited by 71
Results from the Estonian postmenopausal hormone therapy trial [ISRCTN35338757]
Veerus, P., Hovi, S., Fischer, K., Rahu, M., Hakama, M., & Hemminki, E. (2006) · Maturitas · doi:10.1016/j.maturitas.2006.01.012 · Cited by 69
Obel, E. B., Munk‐Jensen, N., Svenstrup, B., Bennett, P., Mičić, S., Henrik-Nielsen, R., Nielsen, S. P., Gydesen, H., & Jensen, B. (1993) · Maturitas · doi:10.1016/0378-5122(93)90129-6 · Cited by 68
Prentice, R. L., Pettinger, M. B., Beresford, S. A. A., Wactawski‐Wende, J., Hubbell, F. A., Stefanick, M. L., & Chlebowski, R. T. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-1209 · Cited by 68
Tang, J. Y., Spaunhurst, K. M., Chlebowski, R. T., Wactawski‐Wende, J., Keiser, E., Thomas, F., Anderson, M. L., Zeitouni, N. C., Larson, J. C., & Stefanick, M. L. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr333 · Cited by 68
Effect of 10 Years' Hormone Replacement Therapy on Bone Mineral Content in Postmenopausal Women
Eiken, P. (1996) · Bone · doi:10.1016/s8756-3282(96)00266-9 · Cited by 64
Vickers, M. R., Martin, J., Meade, T. W., & the WISDOM study team (2007) · BMC Women s Health · doi:10.1186/1472-6874-7-2 · Cited by 63
Rationale, Design, and Conduct of the PEPI Trial
Espeland, M. A. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)00033-y · Cited by 60
Postmenopausal Hormone Use and the Risk of Nephrolithiasis
Maalouf, N. M., Sato, A., Welch, B. J., et al. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.342 · Cited by 58
Espeland, M. A., Brunner, R. L., Hogan, P. E., Rapp, S. R., Coker, L. H., Legault, C., Granek, I. A., Resnick, S. M., & for the Women's Health Initiative Study of Cognitive Aging Study Group (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02953.x · Cited by 57
Pefanco, M. A., Kenny, R. A., Kaplan, R. F., Kuchel, G. A., Walsh, S. J., Kleppinger, A., & Prestwood, K. M. (2007) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2007.01085.x · Cited by 55
Karim, R., Mack, W. J., Lobo, R. A., Hwang, J., Liu, C., Liu, C.-H., Sevanian, A., & Hodis, H. N. (2005) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000153934.76086.a4 · Cited by 54
Haines, C. J., Yim, S. F., Chung, T. K. H., Lam, C. W. K., Lau, E. W. C., Ng, M. H. L., Chin, R., & Lee, D. T. S. (2003) · Maturitas · doi:10.1016/s0378-5122(02)00340-7 · Cited by 52
Effect of estrone sulfate on postmenopausal bone loss
Genant, H. K., Baylink, D. J., Gallagher, J. C., Harris, S. T., Steiger, P., & Herber, M. (1991) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(91)90313-t · Cited by 52
Nielsen, T. F., Ravn, P., Bagger, Y. Z., Warming, L., & Christiansen, C. (2004) · Osteoporosis International · doi:10.1007/s00198-003-1535-8 · Cited by 47
Bech, P., Munk‐Jensen, N., Obel, E. B., Ulrich, L. G., Eiken, P., & Nielsen, S. P. (1998) · Psychotherapy and Psychosomatics · doi:10.1159/000012289 · Cited by 46
Hemminki, E., & McPherson, K. (2000) · The Lancet · doi:10.1016/s0140-6736(99)03432-7 · Cited by 44
The Effect of Ultralow-Dose Transdermal Estradiol on Urinary Incontinence in Postmenopausal Women
Waetjen, L. E., Brown, J. S., Vittinghoff, E., Ensrud, K. E., Pinkerton, J. V., Wallace, R. B., Macer, J. L., & Grady, D. G. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000182576.48290.6d · Cited by 44
A Practical Guide to Prescribing Hormone Replacement Therapy
McKinney, K. A., & Thompson, W. (1998) · Drugs · doi:10.2165/00003495-199856010-00005 · Cited by 42
Herrington, D. M., Fong, J., Sempos, C. T., Black, D. M., Schrott, H. G., Rautaharju, P. M., Bachorik, P. S., Blumenthal, R. S., Khan, S. S., & WENGER, N. K. (1998) · American Heart Journal · doi:10.1016/s0002-8703(98)70191-7 · Cited by 41
Pulsed estrogen therapy improves postmenopausal quality of life: a 2-year placebo-controlled study
Nielsen, T. F., Ravn, P., Pitkin, J., & Christiansen, C. (2006) · Maturitas · doi:10.1016/j.maturitas.2005.04.003 · Cited by 40
Hall, G., Pripp, U., Schenck-Gustafsson, K. G., & Landgren, B. (1998) · Maturitas · doi:10.1016/s0378-5122(97)00080-7 · Cited by 40
Notelovitz, M., John, V. A., & Good, W. R. (2002) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200209000-00007 · Cited by 40
Chen, F.-P., Lee, N., Soong, Y.-K., & Huang, K. (2001) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200109000-00009 · Cited by 39
Estrogen after ischemic stroke: Clinical basis and design of The Women's Estrogen for Stroke Trial
Kernan, W. N., Brass, L. M., Viscoli, C. M., Sarrel, P. M., Makuch, R., & Horwitz, R. I. (1998) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/s1052-3057(98)80026-8 · Cited by 36
Os, I., Hofstad, A.-E., Brekke, M., Abdelnoor, M., Nesheim, B. I., Jacobsen, A. F., Birkeland, K. I., Larsen, A., Midtbø, K., & Westheim, A. S. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00675.x · Cited by 34
Teede, H. J., Liang, Y.-L., Kotsopoulos, D., Zoungas, S., Craven, R., & McGrath, B. P. (2002) · Climacteric · doi:10.1080/cmt.5.2.160.169 · Cited by 32
Baseline Characteristics of the PEPI Participants
Miller, V., Byington, R. L., Espeland, M. A., Langer, R., Marcus, R., Shumaker, S., & Stern, M. P. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)00113-h · Cited by 31
Pedersen, A. T. (2003) · Human Reproduction · doi:10.1093/humrep/deg435 · Cited by 29
Diem, S., Grady, D., Quan, J., Vittinghoff, E., Wallace, R., Hanes, V., & Ensrud, K. (2006) · Menopause · doi:10.1097/01.gme.0000192439.82491.24 · Cited by 28
Sl, C., Rm, R., Caubel, P., & Lim, P. (1999) · PubMed · Cited by 28
Symptom reporting and quality of life in the Estonian Postmenopausal Hormone Therapy Trial
Veerus, P., Fischer, K., Hovi, S., Karro, H., Rahu, M., & Hemminki, E. (2008) · BMC Women s Health · doi:10.1186/1472-6874-8-5 · Cited by 27
Climacteric vasomotor symptoms do not imply autonomic dysfunction
Virtanen, I., Polo‐Kantola, P., Erkkola, R. U., Polo, O. J., & Ekholm, E. M. K. (1999) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1999.tb08216.x · Cited by 25
Women's Angiographic Vitamin and Estrogen trial:
Hsia, J. A., Alderman, E. L., Verter, J. I., Rogers, W. J., Thompson, P. D., Howard, B. V., Cobb, F. R., Ouyang, P., Tardif, J., Higginson, L., et al. (2002) · Controlled Clinical Trials · doi:10.1016/s0197-2456(02)00237-4 · Cited by 24
Unopposed Estradiol Therapy in Postmenopausal Women
Steiner, A. Z., Xiang, M., Mack, W. J., Shoupe, D., Felix, J. C., Løbo, R. A., & Hodis, H. N. (2007) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000251518.56369.eb · Cited by 24
Post, M. S., van der Mooren, M. J., van Baal, W. M., Neele, S. J. M., Netelenbos, J. C., & Kenemans, P. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.117340 · Cited by 22
Reboussin, B. A., Greendale, G. A., & Espeland, M. A. (1998) · Climacteric · doi:10.3109/13697139809085538 · Cited by 22
Bibbins-Domingo, K. B., Lin, F., Vittinghoff, E., Barrett-Connor, E. L., Hulley, S. B., Grady, D. G., & Shlipak, M. G. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.09.021 · Cited by 21
The ERA trial: findings and implications for the future
Nair, G. V., & Herrington, D. M. (2000) · Climacteric · doi:10.1080/13697130008500132 · Cited by 21
Effects of Long-Term Transdermal Administration of Estradiol on Serum Lipids
Ory, S. J., Field, C. S., Herrmann, R. R., Zinsmeister, A. R., & Riggs, B. L. (1998) · Mayo Clinic Proceedings · doi:10.4065/73.8.735 · Cited by 21
Treatment adherence in the Estonian postmenopausal hormone therapy (EPHT) trial [ISRCTN35338757]
Vorobjov, S., Hovi, S., Veerus, P., Pisarev, H., Rahu, M., & Hemminki, E. (2005) · Maturitas · doi:10.1016/j.maturitas.2005.05.001 · Cited by 17
Jm, A., Hart, D. M., Lindsay, R. J., Jb, A., Da, S., & Gm, W. (1976) · PubMed · Cited by 15
Os, I., Os, A., Sandset, P. M., Bølling, S., Seljeflot, I., Djurovic, S., & Westheim, A. S. (2002) · Cardiology · doi:10.1159/000064667 · Cited by 15
Hormone replacement therapy: discrepancies between evidence and recommendations
Hemminki, E. (2000) · Scandinavian Journal of Public Health · doi:10.1177/140349480002800201 · Cited by 13
Khan, M. A., Hlatky, M. A., Liu, M. W., Lin, F., Rogers, W. J., & Shlipak, M. G. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00121-8 · Cited by 10
Bittner, V., Tripputi, M., Hsia, J. A., Gupta, H., & Steffes, M. W. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.01.025 · Cited by 9
Simon, J. A. (2003) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(03)00113-3 · Cited by 9
LOWE, J. M. (2002) · BMJ Evidence-Based Medicine · doi:10.1136/ebm.7.5.137 · Cited by 7
Cited by
Bushnell, C., McCullough, L. D., Awad, I. A., Chireau, M. V., Fedder, W. N., Furie, K. L., Howard, V. J., Lichtman, J. H., Lisabeth, L. D., Piña, I. L., et al. (2014) · Stroke · doi:10.1161/01.str.0000442009.06663.48 · Cited by 941
Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline
Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2236 · Cited by 884
Estrogens and androgens in skeletal physiology and pathophysiology
Almeida, M., Laurent, M. R., Dubois, V., Claessens, F., O'Brien, C. A., Bouillon, R., Vanderschueren, D., & Manolagas, S. C. (2017) · Physiological Reviews · doi:10.1152/physrev.00033.2015 · Cited by 860
UK clinical guideline for the prevention and treatment of osteoporosis
The National Osteoporosis Guideline Group (NOGG), Compston, J., Cooper, A., Cooper, C., Gittoes, N., Gregson, C., Harvey, N., Hope, S., Kanis, J. A., McCloskey, E. V., et al. (2017) · Archives of Osteoporosis · doi:10.1007/s11657-017-0324-5 · Cited by 826
Sammaritano, L. R., Bermas, B. L., Chakravarty, E. E., Chambers, C., Clowse, M. E. B., Lockshin, M. D., Marder, W., Guyatt, G., Branch, D. W., Buyon, J., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41191 · Cited by 790
Metadata
- Authors
- Marjoribanks, J., Farquhar, C., Roberts, H., & Lethaby, A.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2012-07-11
- Issue
- 7
- Pages
- CD004143-CD004143
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W4243571535
- Cited by
- 278
- References
- 173
- Type
- reference entry
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.